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Atherosclerosis-related cardiovascular disease is one of the 
leading causes of death in China [1]. With advances in our 
understanding of the molecular mechanisms of atheroscle-
rosis vascular inflammation, lipid metabolism dysfunction, 
and hypertension are regarded as the main pathogenetic 
pathways of both early atherogenesis and advanced plaque 
rupture [2,3]. Currently, much attention is being paid to the 
control of these pathways, which offers the potential for 
development of novel therapeutic approaches in the treat-
ment of cardiovascular disease in China. 
In the past few decades, considerable evidence has under- 
scored that atherosclerosis is a chronic inflammatory di- 
sease of the arterial wall, where numerous molecular in-
flammatory components such as organophosphate and lipo- 
polysaccharide (LPS) play crucial roles in the development 
of atherosclerosis [4,5]. ATP-binding cassette transporter 
A1 (ABCA1), a cytomembrane transporter first cloned in 
1994, has been identified as playing a key role in choles- 
terol reverse transport (RCT), which is regarded as an-
ti-atherosclerotic. Evidence from many recent studies indi-
cates that inflammation impairs RCT, and many atherogen-
ic-related mediators play distinct regulatory roles in 
ABCA1 expression [2]. Liu and colleagues [6] (South Cen-
tral University) investigated the effect of paraoxon, an ac-
tive metabolite of organophosphorus insecticide that in-
creases cholesterol retention in macrophages [4], on  
ABCA1 expression and ABCA1-dependent cholesterol ef-
flux in RAW 264.7 macrophage-derived foam cells,    
and found that paraoxon significantly downregulated 
ABCA1 expression and reduced ABCA1-dependent cho-
lesterol efflux through cyclic AMP signaling pathway.  
Our group [7,8] (University of South China) found that LPS 
and interferon (IFN)-γ can downregulate expression of 
ABCA1 and promote accumulation of lipid and decrease 
cellular cholesterol efflux in THP-1 macrophage-derived 
foam cells. 
Vascular endothelial dysfunction is known as the primary 
step in vascular inflammation and atherogenesis. Liu and 
colleagues [9] (Peking Union Medical College and Chinese 
Academy of Medical Sciences) discovered that human 
paraoxonase gene cluster transgenic overexpression re-
presses atherogenesis and promotes atherosclerotic plaque 
stability in apoE-null mice. They also found that endothe-
lium-specific overexpression of class III deacetylase SIRT1 
decreases atherosclerosis in apoE-deficient mice [10]. Liu et 
al. [11] (Central South University) found that treatment 
with paraoxon resulted in significant inhibition of endothe-
lium-dependent relaxation (EDR) in rabbits as well as a 
significant decrease of endothelial nitric oxide synthase 
(eNOS) activity in isolated aorta. These findings suggest 
that subchronic exposure to environmentally relevant matter 
such as LPS and organophosphate, even at low concentra-
tions, potentiates inflammation, cholesterol retention, and  
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athero-sclerosis. 
It is worth noting that some Chinese traditional medicine 
and nutritive material from food may be useful for preventing 
and treating endothelial dysfunction and inflammatory  
response. Wen et al. [12] (Hebei Medical University) inves-
tigated the effects of 1,6-O,O-acetylbritannilactone 
(ABLO2), an extract of Inula britannica L., on activation of 
endothelial cells and its interaction with macrophages 
treated with LPS, and found that ABLO2 inhibited adhesion 
between endothelial cells and macrophages by decreasing 
expression of vascular cell adhesion molecules via inhibiting 
NF-κB activation by blocking IκB kinase (IKK) activation. 
Ma and colleagues [13] (Hebei Medical University) inves-
tigated the effects of eicosapentaenoic acid (EPA) on the 
release of inflammatory cytokines in human endothelial 
cells stimulated by LPS, and found that EPA inhibits 
LPS-induced production of inflammatory cytokines such as 
VEGF, IL-1α, and IL-6 in cultured HUVECs via suppressing 
activation of NF-κB. 
A crucial feature of vulnerable plaques is the necrotic 
core, which contributes to inflammation, thrombosis, and 
proteolytic plaque breakdown [3]. Necrotic cores arise 
partly from apoptosis of advanced lesional macrophages. 
Although the significance of apoptosis in atherosclerosis 
depends on the stage of the plaque, sustained induction of 
apoptosis in advanced lesions seems to favor arterial wall 
inflammation and enhances recruitment of monocytes, 
leading to increased plaque burden [14]. Recently, many 
lipid metabolism-related genes have been found to play 
special roles in regulation of apoptosis. Proprotein con- 
vertase subtilisin/kexin 9 (Pcsk9), a central player in the 
regulation of levels of the LDL receptor, was recently iden-
tified to play a special role in macrophages apoptosis. Liu et 
al. [15] (University of South China) found that apoptosis of 
THP-1-derived macrophages induced by oxLDL could be 
effectively suppressed by pcsk9 siRNA, suggesting a novel 
role for pcsk9 in the development of inflammation and athero- 
sclerosis. As a multifunctional regulator in cholesterol me-
tabolism of mammal cells, Daxx has been suggested to play 
a special role in the function of macrophages, although the 
exact mechanisms remain to be elucidated [16]. Liao et al. 
[17] (Hunan University of Chinese Medicine) reported that 
Daxx mediates oxLDL-induced macrophages apoptosis by 
upregulating expression of caveolin-1. 
Accumulation of free cholesterol (FC) in the endo-  
plasmic reticulum (ER) is also a cause of macrophage 
apoptosis. ABCA1 plays a key role in removing intracellular 
FC into vesicles that are translocated to the plasma membrane 
for exocytosis, suggesting a unique role for ABCA1 in  
protecting FC loading, ER stress, and oxidized lipids-  
mediated apoptosis [2]. Apoptosis of vascular smooth mus-
cle cells (VSMCs) has also been identified as an important 
process in restenosis after percutaneous coronary interven-
tion (PCI) [18]. Han and coworkers [19] (Fourth Military 
Medical University) revealed that E1A-stimulated genes 
(CREG), a recently described glycoprotein that plays a  
crucial role in cellular or tissue homeostasis, plays a key 
role in modulating VSMC apoptosis by p38/JNK signaling 
transduction pathway in vitro, suggesting a potential thera-
peutic target for attenuating the progression of atheroscle-
rotic plaques and restenosis after PCI. This was the first 
study to show that CREG is involved in VSMC apoptosis. 
Necrosis, another form of cell death, often results in 
more serious inflammation, organ failure, or mortality in 
atherosclerosis-related cardiovascular disease [20]. Lin et al. 
[21] (Nanjing University) investigated the cell death mode 
switch from necrosis to apoptosis in hydrogen peroxide- 
treated macrophages, and found that negative feedback  
between NF-κB and MAPKs is implicated in converting 
necrosis into apoptosis in macrophages exposed to hydro-
gen peroxide. 
Essential hypertension (EH) is a complex disease caused 
by interaction of genetic and environmental factors, in 
which impairment of constriction and relaxation of vascular 
ring is the main pathophysiologic characteristic [22]. Chen 
et al. [23] (University of South China) reported that the  
diastolic reactivity of apelin-13, a G protein-coupled recep-
tor APJ endogenous ligand, is reduced in ex vivo vascular 
rings of spontaneously hypertensive rat (SHR) via NO- and 
ERK1/2-dependent pathways. Gao et al. [24] (People’s 
Liberation Army 323rd Hospital) also found that apelin-13 
decreased systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) in SHR. These results provide new insights 
for understanding the function of apelin in EH. 
Endothelial lipase (EL) is an important determinant of 
high-density lipoprotein (HDL) metabolism and inflamma-
tion acting at the vessel wall. Liao et al. [25] (Hunan Uni-
versity of Chinese Medicine) investigated the effect of high 
hydrostatic pressure on expression of EL, and revealed that 
hydrostatic pressure increased mRNA and protein expres-
sion level of EL in human umbilical vein endothelial cells, 
which may be related to nuclear factor-κB signal pathways. 
Their findings suggest that EL may be a possible link be-
tween hypertension and vascular inflammation. 
The roles for microRNAs (miRNAs) in cardiac hyper-
trophy and heart failure are well documented. However, 
little is known about the roles of miRNAs in EH. Recently, 
Xin and colleagues [26] (Capital Medical University) re-
ported for the first time a circulating miRNA profile for 
hypertensive patients using microarray-based miRNA ex-
pression profiling, and found that 27 miRNAs including 
miR-296-5p, let-7e, and a human cytomegalovirus-encoded 
miRNA were differentially expressed between hypertensive 
patients and control subjects, suggesting that miRNA is a 
new frontier in EH research. The enzyme eNOS plays an 
important role in maintaining normal relaxation of coronary 
arteries. Ou et al. [27] (University of South China) revealed 
a new mechanism for eNOS expression, which was mediated 
by 27-nt miRNA located in intron 4 of eNOS gene. Their 
data further revealed that the expression of transcription 
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factors Sp-1 and Ap-1 was altered by 27-nt miRNA, sug-
gesting that 27-nt miRNA may play a potential role in de-
velopment of EH via regulating expression of eNOS. Glob-
ular actin has been reported to increase activity of eNOS. Ji 
et al. [28] (Nanjing Medical University) have shown that 
eNOS agonists such as adenosine and histamine can regu-
late eNOS activity through affecting its association with 
globular actin, providing a novel mechanism for regulating 
eNOS activity by eNOS agonists. 
Dysfunction of lipid metabolism including hypertriacyl-
glyceridemia and hypercholesterolemia is well established 
as an independent risk factor for atherosclerosis-related car-
diovascular disease [29]. Liu and colleagues [30] (Beijing 
University Medical Center) have observed spontaneous ath-
erosclerosis arising in aged lipoprotein lipase (a rate-limit- 
ing enzyme in hydrolysis of triacylglycerides in plasma 
VLDL)-deficient mice with severe hypertriacylglyceridemia 
on a normal chow diet, indicating a strong association be-
tween hypertriacylglyceridemia and coronary arterioscle-
rotic disease. Our group [31] (University of South China) 
has established that activation of liver X receptor, a crucial 
mediator in lipid metabolism, reduces atherosclerotic le-
sions in apoE-null mice by upregulating NPC1 expression 
and HDL levels. An early event leading to the genesis of 
atherosclerosis is accumulation of cholesterol and other 
lipids within the arterial wall, which were taken up by 
scavenger receptors such as scavenger receptor A. Deng et 
al. [32] (Beijing University of Aeronautics and Astronautics) 
found that accumulation of lipids within the arterial wall is 
positively correlated with concentration polarization of ath-
erogenic lipids, and the integrity of the endothelium plays 
an important role in penetration and accumulation of ather-
ogenic lipids in blood vessel walls. 
Berberine, an alkaloid derived from Chinese goldthread, 
has been identified as lowering serum cholesterol levels. 
The effect of berberine on atherosclerosis development, 
however, remains to be determined. Liao and colleagues [33] 
(Shanghai Institute of Biological Sciences, Chinese Acad-
emy of Science) recently discovered that berberine pro-
motes the development of atherosclerosis and foam cell 
formation by inducing scavenger receptor A expression in 
macrophages, suggesting that promotion of foam cell for-
mation could counterbalance the beneficial effect of lower-
ing serum cholesterol for berberine. Semen Cassiae (Cassia 
seed), a traditional Chinese herbal medicine, has been found 
to decrease serum cholesterol concentration. Li et al. [34] 
(South China Normal University) isolated a novel protein 
that exerts inhibitory effects on cholesterol biosynthesis 
from Senna obtusifolia seed by gel filtration and ion ex-
change chromatography. Their study may provide a novel 
treatment for regulation of hypolipidemic action. 
Identification and quantification of lipids is of major im-
portance for the diagnosis, prognosis, and understanding of 
the molecular mechanisms involved in atherosclerosis-  
related cardiovascular disease [35]. Lipidomics is sys-
tems-level analysis and characterization of lipids and their 
interacting moieties, which has been met by growing inter-
est in the field of cardiovascular disorders, potentially lead-
ing to discovery of novel biomarkers and the development 
of new therapies [36]. There have been few studies on the 
application of lipidomics methods in cardiovascular disease 
research in China to date. However, Yang et al. [37] (Chi-
nese Academy of Sciences) and Zhong et al. [38,39] (Chi-
nese Academy of Agricultural Sciences) reviewed and 
summarized recent progress in this field of research includ-
ing the present situation and future applications. They then 
introduced a direct-infusion, high-throughput analytical 
strategy, namely electrospray ionization tandem mass spec-
trometry (ESI-MS/MS), and provided an overview of ap-
plication advances of this approach in lipidomics. These 
papers give explicit information on the development of lip-
idomics and a clear understanding of application in this 
newly emerging field. 
Yuan et al. [40] (Tianjin University) recently profiled 
phospholipids in human endothelial cells under oxidative 
stress by a novel lipidomics approach combining liquid 
chromatography (LC)-ion trap MS and LC-tandem quadru-
pole MS. They thus identified the 28 most discriminant spe-
cies in response to different levels of oxidative stress in-
duced by hydrogen peroxide, which also induced phosphor-
ylation of cytosolic phospholipase A(2) (cPLA[2]) via acti-
vation of ERK1/2, and increased production of some phos-
pholipids. Their study provided a novel application for a 
combined lipidomics and signal transduction approach. 
The underlying mechanisms by which atherosclerosis is 
initiated and progresses have attracted much attention all 
over the world, including in China. Atherosclerosis is a dy-
namic process wherein multiple risk factors form a complex 
network with systematic regulation. Future investigations 
should attempt to link how these factors might be integrated 
at a cellular level with other pathways such as lipoprotein 
oxidative stress. Here, we introduced some work mainly 
focusing on inflammation, lipid metabolism dysfunction, 
and hypertension related to atherosclerosis-related cardio-
vascular disease in China. Other important work in oxida-
tive stress and immunology was beyond the scope of this 
review. As investigations continue, we believe that addi-
tionally meaningful results will be obtained in China. 
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